U.S. federal trademark · Serial No. 87832107 · Reg. No. 7507827
T-cell pharmaceutical products for the treatment of cancer
Biotechnology services, namely, the development of T-cell pharmaceutical products and technologies for use in the treatment of cancer
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.